Abstract
Pain management remains a significant clinical challenge, with many patients experiencing inadequate relief from conventional therapies. Recent advances in pharmacology have led to the development of novel analgesics that target various pain pathways more effectively, with fewer side effects. This article reviews recent pharmacological approaches to pain management, including opioid alternatives, targeted therapies for neuropathic pain, and non-opioid analgesics. We also explore the role of cannabinoid-based treatments, gene therapies, and personalized pain management strategies in improving patient outcomes and reducing reliance on opioids.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.